Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

In a new study, researchers investigated the prevalence of cardiovascular disease events (CVE) in people with systemic lupus ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.

In this recording from our virtual webinar on CAR T cell therapy, learn more on this potential treatment option currently being studied in people with severe lupus or lupus nephritis that have not ...